These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29146795)

  • 1. Advancing dengue vaccine development.
    Feinberg MB; Ahmed R
    Science; 2017 Nov; 358(6365):865-866. PubMed ID: 29146795
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for a dengue virus vaccine.
    Whitehead SS; Blaney JE; Durbin AP; Murphy BR
    Nat Rev Microbiol; 2007 Jul; 5(7):518-28. PubMed ID: 17558424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing a dengue vaccination programme-who, where and how?
    E Clapham H; A Wills B
    Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):367-368. PubMed ID: 30016491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversy over dengue vaccine risk.
    Cohen J
    Science; 2019 Sep; 365(6457):961-962. PubMed ID: 31488666
    [No Abstract]   [Full Text] [Related]  

  • 6. Call to action for dengue vaccine failure.
    Mahalingam S; Herring BL; Halstead SB
    Emerg Infect Dis; 2013 Aug; 19(8):1335-7. PubMed ID: 23876389
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.
    Gan ES; Ting DH; Chan KR
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):111-119. PubMed ID: 27796143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.
    Gil L; Martín A; Lazo L
    Front Immunol; 2019; 10():2946. PubMed ID: 31921194
    [No Abstract]   [Full Text] [Related]  

  • 9. Dengue vaccine: reliably determining previous exposure.
    Ariën KK; Wilder-Smith A
    Lancet Glob Health; 2018 Aug; 6(8):e830-e831. PubMed ID: 29941282
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in dengue vaccine development.
    Raviprakash K; Defang G; Burgess T; Porter K
    Hum Vaccin; 2009 Aug; 5(8):520-8. PubMed ID: 19535912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Sanofi Pasteur tetravalent dengue vaccine.
    Lang J
    Rev Inst Med Trop Sao Paulo; 2012 Oct; 54 Suppl 18():S15-7. PubMed ID: 23011454
    [No Abstract]   [Full Text] [Related]  

  • 12. Dengue vaccine prospects: a step forward.
    Guy B; Almond J; Lang J
    Lancet; 2011 Jan; 377(9763):381-2. PubMed ID: 21277439
    [No Abstract]   [Full Text] [Related]  

  • 13. Dengue vaccines: state of the art.
    Swaminathan S; Batra G; Khanna N
    Expert Opin Ther Pat; 2010 Jun; 20(6):819-35. PubMed ID: 20384534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vaccine: opportunities and challenges.
    Hatch S; Mathew A; Rothman A
    IDrugs; 2008 Jan; 11(1):42-5. PubMed ID: 18175262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinations in disease models with antibody-dependent enhancement.
    Billings L; Fiorillo A; Schwartz IB
    Math Biosci; 2008 Feb; 211(2):265-81. PubMed ID: 17923138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue vaccines: strongly sought but not a reality just yet.
    del Angel RM; Reyes-del Valle J
    PLoS Pathog; 2013; 9(10):e1003551. PubMed ID: 24098108
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune correlates for dengue vaccine development.
    Srikiatkhachorn A; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):455-65. PubMed ID: 26560015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004).
    Hadinegoro SR; Arredondo-García JL; Guy B; Bouckenooghe A; Noriega F; Jackson N
    Vaccine; 2016 Aug; 34(36):4273-4. PubMed ID: 27452651
    [No Abstract]   [Full Text] [Related]  

  • 20. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
    Pitisuttithum P; Bouckenooghe A
    Expert Rev Vaccines; 2016 Jul; 15(7):795-8. PubMed ID: 27171845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.